Literature DB >> 11129402

The endothelium and thrombosis.

P L Gross1, W C Aird.   

Abstract

Thrombosis reflects an imbalance between procoagulant and anticoagulant mechanisms. In some cases, thrombotic lesions are precipitated by gross changes in blood flow, vascular wall integrity, or systemic levels of coagulation factors. In other cases, thrombosis is induced by functional changes within the endothelium. Endothelial cells express a wide variety of factors that contribute to hemostasis, including procoagulants, anticoagulants, cell adhesion molecules, vasomotor substances, and cell survival signals. Because the endothelium displays a remarkable diversity of structure and function, the relative contribution of any one of these factors to the hemostatic balance varies between different vascular beds. In this review, we emphasize the heterogeneous nature of endothelial cell function. We then examine the role of endothelial diversity in modulating the phenotypic expression of thrombotic disorders.

Entities:  

Mesh:

Year:  2000        PMID: 11129402     DOI: 10.1055/s-2000-13202

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  17 in total

1.  MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro.

Authors:  Yun Fang; Congzhu Shi; Elisabetta Manduchi; Mete Civelek; Peter F Davies
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

2.  Protein-bound uremic toxins stimulate crosstalk between leukocytes and vessel wall.

Authors:  Anneleen Pletinck; Griet Glorieux; Eva Schepers; Gerald Cohen; Bertrand Gondouin; Maria Van Landschoot; Sunny Eloot; Angelique Rops; Johan Van de Voorde; An De Vriese; Johan van der Vlag; Philippe Brunet; Wim Van Biesen; Raymond Vanholder
Journal:  J Am Soc Nephrol       Date:  2013-09-05       Impact factor: 10.121

3.  Tissue factor inflammatory response regulated by promoter genotype and p38 MAPK in neonatal vs. adult microvascular endothelial cells.

Authors:  Jeffrey S Buzby; Shirley A Williams; Karen L Imfeld; Thomas J Kunicki; Diane J Nugent
Journal:  Inflamm Res       Date:  2014-01-03       Impact factor: 4.575

Review 4.  Engineered Microvessels for the Study of Human Disease.

Authors:  Samuel G Rayner; Ying Zheng
Journal:  J Biomech Eng       Date:  2016-11-01       Impact factor: 2.097

Review 5.  [Blood coagulation disorders in oncological patients].

Authors:  M von Depka Prondzinski
Journal:  Internist (Berl)       Date:  2005-01       Impact factor: 0.743

Review 6.  Pathophysiology of deep vein thrombosis.

Authors:  Simón Navarrete; Carla Solar; Roberto Tapia; Jaime Pereira; Eduardo Fuentes; Iván Palomo
Journal:  Clin Exp Med       Date:  2022-04-26       Impact factor: 3.984

Review 7.  Microvascular platforms for the study of platelet-vessel wall interactions.

Authors:  Ying Zheng; Junmei Chen; José A López
Journal:  Thromb Res       Date:  2014-01-07       Impact factor: 3.944

Review 8.  The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms.

Authors:  Jason V Baker; W Keith Henry; James D Neaton
Journal:  Curr Opin HIV AIDS       Date:  2009-05       Impact factor: 4.283

9.  Roles of IL-6-gp130 Signaling in Vascular Inflammation.

Authors:  Tieying Hou; Brian C Tieu; Sutapa Ray; Adrian Recinos Iii; Ruwen Cui; Ronald G Tilton; Allan R Brasier
Journal:  Curr Cardiol Rev       Date:  2008-08

10.  Plasma fibrinolysis is related to the degree of organ dysfunction but not to the concentration of von Willebrand Factor in critically ill patients.

Authors:  Karim Zouaoui Boudjeltia; Sandra Ollieuz; Michael Piagnerelli; Patrick Biston; Philippe Cauchie; Jean-Louis Vincent; Dany Brohee; Michel Vanhaeverbeek
Journal:  Thromb J       Date:  2009-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.